Melissa Cantley

Research Interests

Bone and Bones Haematology Cancer Biology and Clinical Oncology Musculoskeletal Health

Dr Melissa Cantley

Externally-Funded Research Fellow

School of Pharmacy and Biomedical Science

College of Health

Eligible to supervise Masters and PhD - email supervisor to discuss availability.

In 2006, Melissa completed a Bachelor of Health Sciences at the University of Adelaide followed by Honours (First Class) in Pathology in 2007. To expand on her knowledge in the area of localized pathological bone loss she worked as an NHMRC funded Research Assistant for two years. During this time Melissa helped establish a number of animal models of pathogenic bone loss, including periodontitis, rheumatoid arthritis and peri-implant osteolysis. Additional to this she optimized quantitative methods to assess bone loss using live micro CT scanning.Melissa completed her PhD (October 2013) within the Discipline of Anatomy and Pathology, School of Medical Sciences at the University of Adelaide with the support of an Australian Postgraduate Award. Her research was undertaken in the Bone and Joint Laboratory with the supervision of Associate Professor David Haynes and Professor Mark Bartold. The overall aim of her PhD project was to investigate novel treatments of localized bone loss in chronic inflammatory diseases such as periodontitis, rheumatoid arthritis and prosthetic osteolysis.In 2013 and 2014 Melissa worked as the Research Projects Coordintor, and Learning and Teaching Support Officer in the School of Medical Sciences. Melissa commenced her NHMRC Peter Doherty Early Career Fellowship in June 2014 under the supervision and mentorship of Professor Andrew Zannettino.Dr Cantley is currently a Cancer Council Beat Cancer Early Career Fellow in the Myeloma Research Laboratory, The University of Adelaide and a Faculty Research Fellow, Precision Cancer Medicine Theme at SAHMRI in Adelaide, Australia. Dr Cantley’s research interests revolve around bone cell biology and role of the complex bone microenvironment in disease including the blood cancer multiple myeloma. This involves using patient samples to unravel the role of the bone marrow microenvironment in progression from pre-cancerous stages (monoclonal gammopathy of undetermined significance (MGUS) and smouldering myeloma) to cancerous myeloma. She is also leading projects focused on discovering biomarkers of progression including a national Australian prospective study to discover blood-based markers that can be used to indicate risk of progression in smouldering myeloma.

Understanding the role of the bone microenvironment in the progression of pre-malignancies monoclonal gammopathy of undetermined significance (MGUS) and smouldering myeloma to active myeloma and identifying bone biomarkers of those patients at high risk of progression to myeloma.

Up to 80% of patients who have myeloma are affected by myeloma bone disease, which leads to holes in the bone and associated bone pain and risk of fractures. This occurs as a result of complex interactions and communications between the myeloma plasma cells and the cells in their surrounding environment of the bone marrow, referred to as the microenvironment. In almost all cases of multiple myeloma, patients have the presence of a pre-cancerous stage known as monoclonal gammopathy of undetermined significance (MGUS) and/or smoldering myeloma (SMM). Some patients with smouldering myeloma have stable disease long-term whilst one quarter of patients will rapidly progress to develop myeloma within 2 years of diagnosis. These pre-cancerous stages are recognized as being symptom free and hence patients are closely monitored but do not receive treatment. The presence of bone lesions is not commonly seen in MGUS and smouldering myeloma patients but some research suggests that there is abnormal bone changes that make a patient more susceptible to bone fractures. My research interests focus around understanding these bone changes in pre-cancerous stages and how they may contribute to the progression of malignant myeloma. 

 

Date Position Institution name
2022 - 2027 Cancer Council Beat Cancer Research Fellow University of Adelaide
2020 - 2027 Faculty Fellow SAHMRI
2014 - 2021 NHMRC Early Career Researcher University of Adelaide
2013 - 2014 Research Projects Coordinator The University of Adelaide
2013 - 2014 Learning & Teaching Support Officer The University of Adelaide
2010 - 2014 Part time tutor The University of Adelaide
2010 - 2013 Part time tutor The University of Adelaide
2010 - 2013 Research Assistant (part time) The University of Adelaide
2008 - 2010 NHMRC grant funded Research Assistant The University of Adelaide

Date Type Title Institution Name Country Amount
2015 Award South Australian 2015 Young Tall Poppy Winner The University of Adelaide Australia -
2014 Achievement Australian Society for Medical Research Ross Wishart Finalist The University of Adelaide Australia -
2014 Award Australian Society for Medical Research (ASMR) Domestic Research Award The University of Adelaide Australia $2000
2013 Award Dean’s commendation for Doctoral Thesis Excellence The University of Adelaide Australia -
2012 Award SA Branch ARA Philip Alpers Award for Best Basic Science Presentation The University of adelaide Australia -
2012 Award ANZBMS Best of the best poster as part of (AHMRC) The University of Adelaide Australia -
2011 Award SA Branch ARA Philip Alpers Award for Best Basic Science Presentation The University of Adelaide Australia -
2011 Achievement Australian Society for Medical Research Ross Wishart Finalist The University of Adelaide Australia -

Date Institution name Country Title
2010 - 2013 The University of Adelaide Australia Doctor of Philsophy
2007 - 2007 The University of Adelaide Australia Bachelor of Health Sciences (Honours)
2004 - 2006 The University of Adelaide Australia Bachelor of Health Sciences

Year Citation
2025 Cantley, M. D., Trainor, L. J., Cheney, E. A. -J., Watt, S. M., & Vandyke, K. (2025). Skeletal health in the precursor stages of multiple myeloma: fracture risk and bone phenotypes in monoclonal gammopathy of undetermined significance and smouldering myeloma. Pathology.
DOI
2025 Plakhova, N., Panagopoulos, V., Cantley, M. D., Trainor, L. J., Hewett, D. R., Clark, K. C., . . . Vandyke, K. (2025). Age-related mesenchymal stromal cell senescence is associated with progression from MGUS to multiple myeloma.. Leukemia, 39(6), 1464-1475.
DOI Scopus1 WoS3 Europe PMC1
2025 Tuckey, N., Iasiello, M., Ali, K., Yong, A., Wilson, S., Ryan, M., . . . Wardill, H. R. (2025). The Unmet Psychological Needs of People Living With Multiple Myeloma and Smouldering Myeloma: A Review of Current Approaches and Future Directions. Clinical Lymphoma Myeloma and Leukemia, 25(12), e1145-e1159.
DOI
2020 Algate, K., Haynes, D., Fitzsimmons, T., Romeo, O., Wagner, F., Holson, E., . . . Cantley, M. (2020). Histone deacetylases 1 and 2 inhibition suppresses cytokine production and osteoclast bone resorption in vitro. Journal of Cellular Biochemistry, 121(1), 244-258.
DOI Scopus23 WoS23 Europe PMC20
2017 Cantley, M. D., Zannettino, A. C. W., Bartold, P. M., Fairlie, D. P., & Haynes, D. R. (2017). Histone deacetylases (HDAC) in physiological and pathological bone remodelling. Bone, 95, 162-174.
DOI Scopus47 WoS40 Europe PMC39
2017 Williams, B., Tsangari, E., Stansborough, R., Marino, V., Cantley, M., Dharmapatni, A., . . . Crotti, T. (2017). Mixed effects of caffeic acid phenethyl ester (CAPE) on joint inflammation, bone loss and gastrointestinal inflammation in a murine model of collagen antibody-induced arthritis. Inflammopharmacology, 25(1), 55-68.
DOI Scopus11 WoS10 Europe PMC7
2017 Cantley, M., Rainsford, K., & Haynes, D. (2017). Yeast RNA extract suppresses human osteoclast resorption in vitro. Inflammopharmacology, 25(5), 571-576.
DOI
2017 Dharmapatni, A., Algate, K., Coleman, R., Lorimer, M., Cantley, M., Smith, M., . . . Crotti, T. (2017). Osteoclast-Associated Receptor (OSCAR) Distribution in the Synovial Tissues of Patients with Active RA and TNF-α and RANKL Regulation of Expression by Osteoclasts In Vitro. Inflammation, 40(5), 1566-1575.
DOI Scopus10 WoS10 Europe PMC9
2016 Cantley, M., Dharmapatni, A., Algate, K., Crotti, T., Bartold, P., & Haynes, D. (2016). Class I and II histone deacetylase expression in human chronic periodontitis gingival tissue. Journal of Periodontal Research, 51(2), 143-151.
DOI Scopus29 WoS25 Europe PMC26
2016 Saad, S., Dharmapatni, A., Crotti, T., Cantley, M., Algate, K., Findlay, D., . . . Haynes, D. (2016). Semaphorin-3a, neuropilin-1 and plexin-A1 in prosthetic-particle induced bone loss. Acta Biomaterialia, 30, 311-318.
DOI Scopus22 WoS20 Europe PMC18
2016 Algate, K., Haynes, D., Bartold, P., Crotti, T., & Cantley, M. (2016). The effects of tumour necrosis factor-α on bone cells involved in periodontal alveolar bone loss; osteoclasts, osteoblasts and osteocytes. Journal of Periodontal Research, 51(5), 549-566.
DOI Scopus94 WoS88 Europe PMC72
2016 Ormsby, R., Cantley, M., Kogawa, M., Solomon, L., Haynes, D., Findlay, D., & Atkins, G. (2016). Evidence that osteocyte perilacunar remodelling contributes to polyethylene wear particle induced osteolysis. Acta Biomaterialia, 33, 242-251.
DOI Scopus66 WoS57 Europe PMC43
2016 Williams, B., Tsangari, E., Stansborough, R., Marino, V., Cantley, M., Dharmapatni, A., . . . Crotti, T. (2016). THE EFFECT OF LOW DOSE CAFFEIC ACID PHENETHYL ESTER ON JOINT INFLAMMATION, BONE LOSS AND GASTROINTESTINAL INFLAMMATION IN A COLLAGEN ANTIBODY-INDUCED ARTHRITIS MURINE MODEL. INTERNAL MEDICINE JOURNAL, 46, 28.
2015 Dharmapatni, A., Cantley, M., Marino, V., Perilli, E., Crotti, T., Smith, M., & Haynes, D. (2015). The X-Linked Inhibitor of Apoptosis Protein inhibitor embelin suppresses inflammation and bone erosion in collagen antibody induced arthritis mice. Mediators of Inflammation, 2015(1), 564042-1-564042-10.
DOI Scopus23 WoS20 Europe PMC21
2015 Perilli, E., Cantley, M., Marino, V., Crotti, T., Smith, M., Haynes, D., & Dharmapatni, A. (2015). Quantifying not only bone loss, but also soft tissue swelling, in a murine inflammatory arthritis model using micro-computed tomography. Scandinavian Journal of Immunology, 81(2), 142-150.
DOI Scopus21 WoS19 Europe PMC16
2015 Zawawi, M., Perilli, E., Stansborough, R., Marino, V., Cantley, M., Xu, J., . . . Crotti, T. (2015). Caffeic accid phenethyl ester abrogates bone resorption in a murine calvarial model of polyethylene particle-induced osteolysis. Calcified Tissue International, 96(6), 565-574.
DOI Scopus21 WoS16 Europe PMC17
2015 Cantley, M., Fairlie, D., Bartold, P., Marino, V., Gupta, P., & Haynes, D. (2015). Inhibiting histone deacetylase 1 suppresses both inflammation and bone loss in arthritis. Rheumatology, 54(9), 1713-1723.
DOI Scopus68 WoS66 Europe PMC57
2015 Zawawi, M., Marino, V., Perilli, E., Cantley, M., Xu, J., Purdue, P., . . . Crotti, T. (2015). Parthenolide reduces empty lacunae and osteoclastic bone surface resorption induced by polyethylene particles in a murine calvarial model of peri-implant osteolysis. Journal of Biomedical Materials Research Part A, 103(11), 3572-3579.
DOI Scopus19 WoS16 Europe PMC13
2014 Coleman, R., Dharmapatni, A., Algate, K., Weedon, H., Cantley, M., Wechalekar, M., . . . Crotti, T. (2014). REGULATION OF OSTEOCLAST- ASSOCIATED RECEPTOR ( OSCAR) PRODUCTION BY HUMAN PERIPHERAL BLOOD DERIVED OSTEOCLAST CELLS. INTERNAL MEDICINE JOURNAL, 44(S2), 1.
DOI
2014 Gully, N., Bright, R., Marino, V., Marchant, C., Cantley, M., Haynes, D., . . . Bartold, M. (2014). Porphyromonas gingivalis peptidylarginine deiminase, a key contributor in the pathogenesis of experimental periodontal disease and experimental arthritis. PLoS One, 9(6), e100838-1-e100838-12.
DOI Scopus96 WoS88 Europe PMC87
2013 Cantley, M., Fairlie, D., Bartold, M., Marino, V., Gupta, P., & Haynes, D. (2013). TARGETING HISTONE DEACETYLASE 1 (HDAC 1) TO SUPPRESS BOTH INFLAMMATION AND BONE LOSS IN ARTHRITIS. INTERNAL MEDICINE JOURNAL, 43, 1.
2013 Cantley, M., Rainsford, K., & Haynes, D. (2013). Comparison of the ability of chondroitin sulfate derived from bovine, fish and pigs to suppress human osteoclast activity in vitro. Inflammopharmacology, 21(6), 407-412.
DOI Scopus12 WoS8 Europe PMC8
2013 Cantley, M., Rainsford, K., & Haynes, D. (2013). Effects of Osteochondrin S and select connective tissue ribonucleinate components on human osteoclasts in vitro. Journal of Pharmacy and Pharmacology, 65(8), 1214-1222.
DOI Scopus3 WoS3 Europe PMC3
2013 Gannon, S., Cantley, M., Haynes, D., Hirsch, R., & Bartold, P. (2013). Azithromycin suppresses human osteoclast formation and activity in vitro. Journal of Cellular Physiology, 228(5), 1098-1107.
DOI Scopus21 WoS20 Europe PMC18
2013 Cantley, M., & Haynes, D. (2013). Epigenetic regulation of inflammation: progressing from broad acting histone deacetylase (HDAC) inhibitors to targeting specific HDACs. Inflammopharmacology, 21(4), 301-307.
DOI Scopus64 WoS60 Europe PMC50
2012 Zawawi, M., Dharmapatni, A., Cantley, M., McHugh, K., Haynes, D., & Crotti, T. (2012). Regulation of ITAM adaptor molecules and their receptors by inhibition of calcineurin-NFAT signalling during late stage osteoclast differentiation. Biochemical and Biophysical Research Communications, 427(2), 404-409.
DOI Scopus25 WoS22 Europe PMC18
2012 Cantley, M., Bartold, P., Fairlie, D., Rainsford, K., & Haynes, D. (2012). Histone deacetylase inhibitors as suppressors of bone destruction in inflammatory diseases. Journal of Pharmacy and Pharmacology, 64(6), 763-774.
DOI Scopus27 WoS22 Europe PMC18
2011 Cantley, M., Bartold, P., Marino, V., Fairlie, D., Le, G., Lucke, A., & Haynes, D. (2011). Histone deacetylase inhibitors and periodontal bone loss. Journal of Periodontal Research, 46(6), 697-703.
DOI Scopus65 WoS58 Europe PMC54
2011 Cantley, M., Fairlie, D., Bartold, P., Rainsford, K., Le, G., Lucke, A., . . . Haynes, D. (2011). Inhibitors of histone deacetylases in class I and class II suppress human osteoclasts in vitro. Journal of Cellular Physiology, 226(12), 3233-3241.
DOI Scopus70 WoS70 Europe PMC59
2011 Cantley, M., Haynes, D., Marino, V., & Bartold, P. (2011). Pre-existing periodontitis exacerbates experimental arthritis in a mouse model. Journal of Clinical Periodontology, 38(6), 532-541.
DOI Scopus103 WoS95 Europe PMC87
2010 Bartold, P., Cantley, M., & Haynes, D. (2010). Mechanisms and control of pathologic bone loss in periodontitis. Periodontology 2000, 53(1), 55-69.
DOI Scopus196 WoS184 Europe PMC145
2010 Bartold, P., Marino, V., Cantley, M., & Haynes, D. (2010). Effect of Porphyromonas gingivalis-induced inflammation on the development of rheumatoid arthritis. Journal of Clinical Periodontology, 37(5), 405-411.
DOI Scopus81 WoS69 Europe PMC64
2009 Cantley, M., Smith, M., & Haynes, D. (2009). Pathogenic bone loss in rheumatoid arthritis: Mechanisms and therapeutic approaches. International Journal of Clinical Rheumatology, 4(5), 561-582.
DOI Scopus15
2009 Cantley, M., Bartold, P., Marino, V., Reid, R., Fairlie, D., Wyszynski, R., . . . Haynes, D. (2009). The use of live-animal micro-computed tomography to determine the effect of a novel phospholipase A₂ inhibitor on alveolar bone loss in an in vivo mouse model of periodontitis. Journal of Periodontal Research, 44(3), 317-322.
DOI Scopus21 WoS17 Europe PMC17

Year Citation
2025 Vandyke, K., Plakhova, N., Panagopoulos, V., Cantley, M., Trainor, L., Clark, K., . . . Mrozik, K. (2025). Mesenchymal Stromal Cell Senescence is Associated with Progression from MGUS to Multiple Myeloma. In CLINICAL LYMPHOMA MYELOMA & LEUKEMIA Vol. 25 (pp. 2 pages). CIG MEDIA GROUP, LP.
2011 Dharmapatni, A., Fitzpatrick, D., Cantley, M. D., & Haynes, D. R. (2011). INCREASED SOFAT MRNA EXPRESSION DURING OSTEOCLAST DEVELOPMENT, EVIDENCE THAT SOFAT IS NOT ONLY ASSOCIATED WITH T CELLS. In OSTEOPOROSIS INTERNATIONAL Vol. 22 (pp. S604). Gold Coast, AUSTRALIA: SPRINGER LONDON LTD.
2011 Crotti, T. N., Zawawi, M. S., Dharmapatni, A. A., Cantley, M. D., & Haynes, D. R. (2011). INHIBITION OF ITAM ADAPTOR MOLECULES AND THEIR RECEPTORS BY INHIBITION OF CALCINEURIN-NFAT SIGNALLING DURING LATE STAGE HUMAN OSTEOCLAST DIFFERENTIATION. In OSTEOPOROSIS INTERNATIONAL Vol. 22 (pp. S603). Gold Coast, AUSTRALIA: SPRINGER LONDON LTD.
2011 Cantley, M. D., Fairlie, D. P., Bartold, P., Marino, V., & Haynes, D. R. (2011). INHIBITING HISTONE DEACETYLASES EXPRESSED IN HUMAN PERIODONTAL TISSUES PREVENTS BONE LOSS IN AN ANIMAL MODEL OF PERIODONTAL DISEASE. In OSTEOPOROSIS INTERNATIONAL Vol. 22 (pp. S613). Gold Coast, AUSTRALIA: SPRINGER LONDON LTD.
2010 Cantley, M., Haynes, D. R., & Rainsford, K. D. (2010). EFFECTS OF RIBONUCLEINATE COMPONENTS OF OSTEOCHONDRIN<SUP>R</SUP> S OSTEOARTHRITIS THERAPY ON FORMATION AND ACTIVITY OF HUMAN OSTEOCLASTS <i>IN VITRO</i>. In OSTEOARTHRITIS AND CARTILAGE Vol. 18 (pp. S254-S255). Brussels, BELGIUM: W B SAUNDERS CO LTD.
DOI WoS1
2009 Cantley, M. D., Fairlie, D. P., Bartold, M. P., Rainsford, K. D., & Haynes, D. R. (2009). Inhibition of both class I and class II histone deacetylases is required to effectively inhibit osteoclast bone resorption in vivo and in vitro. In BONE Vol. 44 (pp. S133-S134). Sydney, AUSTRALIA: ELSEVIER SCIENCE INC.
DOI WoS1

Year Citation
2023 Trainor, L. J., Cantley, M. D., King, C., Plakhova, N., Skinner, M., Chai, R., . . . Zannettino, A. (2023). Profiling of patient bone marrow adipocytes in the myeloma microenvironment. Poster session presented at the meeting of Abstracts of the 20th Annual Meeting and Exposition of the International Myeloma Society (IMS 2023), as published in Clinical Lymphoma Myeloma and Leukemia. Athens, Greece: Elsevier.
DOI
2014 Dharmapatni, A., Cantley, M., Marino, V., Perilli, E., Crotti, T., Smith, M., & Haynes, D. (2014). THE X-LINKED INHIBITORY OF APOPTOSIS PROTEIN INHIBITOR, EMBELIN SUPPRESSES INFLAMMATION AND BONE EROSION IN COLLAGEN ANTIBODY INDUCED ARTHRITIS (CAIA) MICE. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY-BLACKWELL.

Fellowships and Scholarships

Cantley MD Cancer Council Beat Cancer Early Career Research Fellowship. Title: Multi-omic approaches to understand and predict development of multiple myeloma ($480,000) (2022-2027)

Cantley MD Faculty of Health and Medical Sciences 2018 Emerging Leadership Mentored Development Program. ($38,885) (2018-2019)

Cantley MD NHMRC Peter Doherty Early Career Fellowship. The effect of histone deacetylase inhibitors on the bone environment in multiple myeloma. ($304,596) (2014-2021).

Cantley MD School of Medical Sciences ‘Kick Start’ Grant Funding $24,950 (2014)

Cantley MD. Group of Eight (G08) supported Fellowship to attend the 64th Lindau Nobel Laureate Meeting June/July $6000 (2014)

Cantley MD. University of Adelaide Fellowship to attend Science in the Dome Event May $500 (2014)

Cantley MD Australian Postgraduate Award ($67,500) (2010-2012)

Grants

  Wardill H., Cantley MD., Iasiello M., van Agteren J., Beer H., Fassnacht D., Ali K., Ramsey I., Edney L., Saleh Moussa. R., Grundy L., Linedale E. 2023 MRFF Consumer-Led Research. The MyWELL study: empowering people with myeloma to not just live, but live well. ($471,648) (2024-2026)

 Zannettino A, Cantley MD. NHMRC Ideas Grant.  Leveraging innovative multi-omic approaches to understand and predict myeloma disease development. ($943,075) (2022-2025)

Cantley MD, Quirk N, Arthur A, Kaur S, Algate K, Breen J. Australian Dental Research Foundation Grant (ADRF). A pilot study to utilise single cell RNA sequencing (scRNA-Seq) to define the bone remodelling microenvironment human periodontitis gingival and bone tissues ($13,500) (2021).

Cantley MD. Bone Health Foundation Seed Grant – Early Career Investigator: Title: Serum CTX-1 levels to predict smouldering myeloma patients at high risk of progression to multiple myeloma: a prospective clinical trial ($21,695.85) (2021-2022).

Cantley MD, Trainor L, Vandyke K, Zannettino A. NanoString Spatial Biology Grant Award. Title: Understanding the bone marrow microenvironment in progression to multiple myeloma (2020).

 Cantley MD. Cancer Australia - Priority-Driven Collaborative Cancer Research Scheme (PdCCRS) Grant – funded by Cancer Australia, Cure Cancer, and Leukaemia Foundation. Title: Using novel high-precision proteomic analysis to discover biomarkers that identify smouldering myeloma patients at high-risk of progression to active multiple myeloma ($199,720) (2020-2022).

Arthur A, Cantley MD. Adelaide Medical School Small Item of Equipment Funding Award. ($1,859) (2019).

Cantley, MD, Arthur A, Zannettino ACW, Gronthos S. Faculty of Health and Medical Sciences Research Infrastructure Funding Award, The University of Adelaide. ($23,840) (2019)

Algate KA, Cantley MD, Haynes DR. Australian Dental Research Foundation Grant. Title: Localized topical histone deacetylase (HDAC) inhibitor treatment as a novel method for treating periodontal disease ($10,651) (2019).

Cantley MD, Haynes DR, Bartold PM, Marino V. Australian Dental Research Foundation Grant, The role of acetylation and Histone Deacetylase 1 (HDAC1) in the relationship between periodontitis and rheumatoid arthritis ($12,762) (2015)

Algate K, Cantley MD, Haynes DR, Bartold PM, Australian Dental Research Foundation Grant, The Effects of Resolvins and Lipoxins on Inflammation Associated Human Osteoclast and Osteoblast activity in vitro ($10,000) (2015)

Haynes DR, Bartold PM, Cantley MD (CIC), NHMRC Project Grant, HDAC 1 and HDAC 5 in periodontitis, ($518,901) (2014-2017).

Cantley MD, Haynes DR, Bartold PM, Marino V, Australian Dental Research Foundation Grant, Targeting HDAC 1 to suppress bone loss in vitro and in a mouse model of periodontitis. $11,813 (2012)

Haynes DR, Bartold PM, Marino V, Cantley MD. Australian Dental Research Foundation Grant, Establishing a mouse model to investigate the relationship between PD and RA  $11,637 (2010)

Undergraduate Teaching and Lecturing

Lecturing

2024, 2025                   Dental Science and Practice 1 Semester 1 3x cartilage and bone lectures.

2021, 2022, 2023,         Dental Science and Practice 1 Semester 1 3x cartilage and bone lectures.

2020, 2019, 2018          Dental Science and Practice 1 Semester 1: 1x connective tissue lecture Semester 2: 3x cartilage and bone lectures.

2016                             Dental Science and Practice 1 (3x guest lectures, Bone and cartilage structure, function and growth)

                                    Biology of Disease (1x guest lecture, multiple myeloma)

2015                             Dental Science and Practice 1 (1x guest lectures, connective tissues)

2014                             Dental Science and Practice 1 (3x guest lectures, Bone and cartilage structure, function and growth) 

2014                             Bachelor of Health Sciences - Biology of Disease (Bone and Joint Diseases)

2013                             Bachelor of Health Sciences - Biology of Disease (Bone and Joint Diseases)

2013                             Bachelor of Health Sciences - Human Biology IB (Research and Science Promotion) 

2011                             Bachelor of Health Sciences - Biology Bridging Course 

2008                             Bachelor of Dental Surgery Biochemistry course 

 

Small group and Tutorials

2022, 2023                   Dental Science and Practice 1, workshop bone growth and formation

2021                             Dental Science and Practice 1 and Bachelor of Oral Health (BOH), Zoom based Q&A sessions on bone and cartilage.

2020                             Dental Science and Practice 1, workshop bone growth and formation

2019, 2021                   The University of Adelaide MBBS 3-year research project supervision

2018                             Small Group Discovery Projects (Bachelor of Health Sciences), Semester 1, Group Leader

2018                             Integrated Learning Activities (ILA) Review session - Dental Science and Practice 1

2016                             Small Group Discovery Projects (Biology of Disease), Group Leader

2016                             Integrated Learning Activities (ILA) Review session - Dental Science and Practice 1

2015                             Supervision of 3rd year Physiology in Action students – laboratory-based research project

2014                             Small Group Discovery Projects (Human Biology IB), Group Leader

2014                             Small Group Discovery Projects (Health Sciences - Biology of Disease), Group Leader

2013                             Small Group Discovery Projects (Health Sciences - Human Biology IB), Group Leader

2012                             Supervised small group research projects (Health Sciences - Structural Cell Biology) 

2010-2014                    Undergraduate tutor in School of Dentistry - Integrated learning activities (ILA) for first year Bachelor of Dental Surgery 1 research review sessions and large group sessions, 2010

2010-2014                    School of Medical Sciences (Human Biology IA and IB, Cells, Tissues and Development (second year), Cells and Tissues (second year), Cells and Tissues (second year).

2010                             Bachelor of Dental Surgery 2 - Biochemistry, Problem based learning (PBL) sessions.

Date Role Research Topic Program Degree Type Student Load Student Name
2025 Co-Supervisor Dietary interventions for protection from chemotherapy-induced bone loss Doctor of Philosophy Doctorate Full Time Miss Linjie Zhang
2024 Co-Supervisor Building the mental health and wellbeing of patients diagnosed with Multiple Myeloma - an incurable cancer Doctor of Philosophy Doctorate Full Time Mrs Natalie Tuckey
2022 Principal Supervisor Lipidomic and metabolomic profiling of the bone marrow microenvironment to understand multiple myeloma disease development Doctor of Philosophy Doctorate Part Time Miss Mackenzie Rose Skinner
2022 Co-Supervisor Genetic and biochemical characterisation of the SIK3 mutation, R393H: A causal mutation that helps define a new family of human monogenetic disorders Doctor of Philosophy Doctorate Full Time Eliana Gloria Stanziano
2020 Co-Supervisor Changes in the bone marrow microenvironment with progression to multiple myeloma Doctor of Philosophy Doctorate Part Time Miss Laura Joy Trainor

Date Role Research Topic Program Degree Type Student Load Student Name
2014 - 2018 Co-Supervisor Epigenetic Regulation of Cells Involved in Periodontal Bone Destruction Through Targeted Histone Deacetylase Inhibition Doctor of Philosophy Doctorate Full Time Kent Algate

Date Role Research Topic Location Program Supervision Type Student Load Student Name
2015 - 2015 Co-Supervisor Low Dose CAPE Treatment in a Collagen-antibody Induced Arthritis Model of Inflammatory Arthritis The University of Adelaide - Honours Full Time Bonnie Williams
2015 - 2015 Principal Supervisor Investigating effects of novel Histone Deacetylase Inhibitors on the relationship between periodontitis and rheumatoid arthritis The University of Adelaide Honours Honours Full Time Ornella Romeo
2014 - 2015 Principal Supervisor Inflammation and bone loss in periodontitis The University of Adelaide - Other Full Time Anne Duong
2014 - 2014 Co-Supervisor HISTONE DEACETYLASE 1 REGULATION IN PERI-PROSTHETIC OSTEOLYSIS The University of adelaide - Honours Full Time Emma Murison
2013 - 2013 Co-Supervisor Regulation of bone loss by targeting histone deacetylase enzymes The University of Adelaide - Honours Full Time Mr Kent Algate

Date Role Board name Institution name Country
2021 - ongoing Board Member Australian Society for Medical Research (ASMR) Board of Directors Australian Society for Medical Research (ASMR) Australia
2015 - ongoing Member Inflammopharmacology Editorial Board Springer Australia

Date Role Committee Institution Country
2021 - ongoing Co-Chair Australian and New Zealand Bone and Mineral Society (ANZBMS) Early Career Investigator Committee (ECIC) Australian and New Zealand Bone and Mineral Society (ANZBMS) Australia
2020 - ongoing Member Member of the Australian New Zealand Bone and Mineral Society (ANZBMS) Early Career Investigator Committee (ECIC) - Events Subcommittee Australian and New Zealand Bone and Mineral Society (ANZBMS) Australia
2020 - ongoing Member International Federation of Musculoskeletal Societies (IFMRS) HubLE Snippets International Federation of Musculoskeletal Societies (IFMRS) HubLE Germany
2018 - ongoing Member Member of the Australian New Zealand Bone and Mineral Society (ANZBMS) Early Career Investigator Committee Garvan Institute for Medical Research Australia
2018 - ongoing Member SAHMRI E/MCR Working Group SAHMRI Australia
2015 - 2015 Secretary Australian Society for Medical Research (ASMR) SA Committee The University of Adelaide Australia
2013 - 2013 Chair Australian Society for Medical Research (ASMR) SA Committee - Media Convener The University of Adelaide Australia
2012 - 2012 Member Australian Society for Medical Research (ASMR) SA Committee - public outreach The University of Adelaide Australia
2011 - 2013 Co-Founder Health Sciences Postgraduate Student Representative groups The University of Adelaide Australia
2011 - 2012 Member Faculty of Health Sciences Higher Degree by Research Committee - Domestic Student Representative The University of Adelade Australia
2011 - 2012 Member School of Medical Sciences - Higher Degree by Research Student Representative The University of Adelaide Australia
2011 - 2013 Member School of Medical Sciences Health and Safety Committee - student representative The University of Adelaide Australia
2011 - 2012 Member Discipline of Anatomy and Pathology - Postgraduate Student Representative The University of adelaide Australia
2009 - 2009 Member Organising Committee, Australian and New Zealand Orthopaedic research Society (ANZORS) Scientific Meeting The University of Adelaide Australia

Date Role Membership Country
2020 - ongoing Member American Society for Bone and Mineral Research (ASBMR) United States
2008 - ongoing Member Australian Bone and Mineral Society (ANZBMS) Australia
2008 - ongoing Member Australian Society for Medical Research (ASMR) Australia

Date Role Editorial Board Name Institution Country
2015 - ongoing Member Inflammopharmacology The University of Adelaide Australia

Connect With Me

External Profiles

Other Links